Nestlé in­vests $145M in Aim­mune’s food al­ler­gy R&D work, tak­ing the head seat at the deal ta­ble

Nestlé Health Sci­ence is mak­ing an­oth­er big in­vest­ment in an emerg­ing biotech com­pa­ny. The Bris­bane, CA-based Aim­mune $AIMT is sell­ing a whop­ping $145 mil­lion stake …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER